Drug Recall Totals for 2008 Highlight Global Outsourcing and Other Risks
This article was originally published in The Gold Sheet
Drug recalls surged last year as global outsourcing took toll. Inappropriate ingredients from China contributed to record 32 Class I recalls, including heparin adulterant and erectile dysfunction API. Meanwhile, U.S. facilities help drive total recalls to 426 - the highest level in seven years. Economic forces and corporate culture played contributing roles. Sage, Hydrox, Sandoz, KV, Actavis, other recall cases explored.
You may also be interested in...
Another outbreak of B. cepacia at hospital intensive care units in multiple states implicates manufacturing and supply chain controls on aqueous non-sterile drug products, particularly for those marketed over the counter under OTC monographs.
Injectables eclipsed oral solids as 2012 generated the fourth-most recalls ever. Contamination played a major role, particularly in generating several massive recalls at compounding pharmacies, while there were also contraceptive packaging snafus, problems in confronting tablet mix-ups and other issues that generated drug recalls last year.